🇺🇸 CYTK — Cytokinetics, Incorporated

Salud Compra fuerte
← Volver

Precio actual

55,55 USD

Máx. histórico

108,06

1032 días

Split 1:6 del 25/06/2013

Caída desde máximo

-48,59%

Rango 52 semanas

54,16 – 88,31

Variación hoy

-12,66%

Cierre anterior

63,60

Rango de hoy

54,16 – 60,84

Volumen hoy

6.774.495

Peor caída histórica

-97,06%

05/05/2004 → 10/10/2014

Recuperado en 3377 días

Volatilidad anualizada ⓘ

69,41%

Información
Nombre completo
Cytokinetics, Incorporated
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
673
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,39 USD (puede no estar actualizado)
Primera cotización
30/04/2004
Precio actualizado
hace 9 horas
Sobre la empresa

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.

Splits Registrados en el histórico de precios
Fecha Ratio
25/06/2013 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
11/02/2021 23,44 23,93 22,41 22,76 -1,73% 6,48% 434.900
10/02/2021 23,75 24,20 22,67 23,16 -2,07% 6,44% 454.600
09/02/2021 23,80 24,10 23,34 23,65 -0,42% 3,19% 479.600
08/02/2021 23,27 24,27 23,11 23,75 +2,95% 4,98% 589.600
05/02/2021 23,15 23,53 22,97 23,07 +0,79% 2,42% 522.600
04/02/2021 22,97 23,11 22,21 22,89 +0,62% 3,92% 376.400
03/02/2021 22,40 23,80 22,20 22,75 +3,36% 7,14% 1.096.300
02/02/2021 20,27 22,11 19,85 22,01 +9,01% 11,15% 725.500
01/02/2021 19,74 20,30 19,24 20,19 +2,64% 5,37% 1.115.800
29/01/2021 20,00 20,60 19,00 19,67 -1,65% 8,00% 943.300
28/01/2021 20,40 20,60 19,65 20,00 -1,23% 4,66% 1.243.900
27/01/2021 20,10 20,57 19,35 20,25 -0,20% 6,07% 898.400
26/01/2021 20,99 21,36 20,10 20,29 -2,64% 6,00% 569.800
25/01/2021 20,27 20,87 19,92 20,84 +2,36% 4,69% 406.700
22/01/2021 19,83 20,41 19,50 20,36 +1,34% 4,59% 570.300
21/01/2021 20,01 20,27 19,21 20,09 +0,55% 5,30% 627.900
20/01/2021 20,75 20,97 19,85 19,98 +0,45% 5,40% 957.900
19/01/2021 19,04 19,97 18,91 19,89 +4,91% 5,57% 851.000
15/01/2021 19,85 20,46 18,89 18,96 -4,24% 7,91% 743.300
14/01/2021 19,50 20,06 19,00 19,80 +2,75% 5,44% 1.767.300
13/01/2021 19,65 19,80 19,23 19,27 -2,08% 2,90% 514.200
12/01/2021 19,93 20,15 19,55 19,68 -1,60% 3,01% 513.500
11/01/2021 21,73 21,91 19,87 20,00 -7,19% 9,39% 920.800
08/01/2021 21,77 22,25 20,98 21,55 +0,09% 5,83% 579.800
07/01/2021 21,36 21,73 20,95 21,53 +1,03% 3,65% 2.010.100
06/01/2021 19,68 21,63 19,68 21,31 +7,19% 9,91% 892.100
05/01/2021 19,44 20,36 19,25 19,88 +1,64% 5,71% 737.000
04/01/2021 20,79 20,79 19,23 19,56 -5,87% 7,50% 700.100
31/12/2020 20,31 21,09 20,16 20,78 +2,06% 4,58% 786.600
30/12/2020 20,64 21,10 20,02 20,36 -1,17% 5,23% 969.500